Artificial neural networks: a new model for assessing prognostic factors

Artificial neural networks in urology: Update 2000.

Prostate cancer and prostatic diseases·2002

Neural network analysis of the prediction of cancer recurrence following debulking laparotomy and chemotherapy in stages III and IV ovarian cancer.

Molecular urology·2002

Impact of different variables on the outcome of patients with clinically confined prostate carcinoma: prediction of pathologic stage and biochemical failure using an artificial neural network.

Cancer·2001

Evaluation of artificial neural networks for the prediction of pathologic stage in prostate carcinoma.

Cancer·2001

The problem of cutoff levels in a screened population: appropriateness of informing screenees about their risk of having prostate carcinoma.

Cancer·2001

Neural network and regression predictions of 5-year survival after colon carcinoma treatment.

Cancer·2001

Nivolumab plus chemotherapy or ipilimumab versus chemotherapy as first-line treatment for advanced esophageal squamous cell carcinoma: 5-year follow-up results from CheckMate 648.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

SKYSCRAPER-03: A Phase III Study of Tiragolumab Plus Atezolizumab Versus Durvalumab in Locally Advanced, Unresectable, Stage III NSCLC After Platinum-Based Concurrent Chemoradiation.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

A Multimodal Deep Learning Model for Preoperative Prediction of Postoperative Complications in Gastric Cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

SACI-IO HR+: a randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Becotatug vedotin for recurrent/metastatic nasopharyngeal carcinoma (Magic-M001): a multicenter, randomized trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Prompt-directed ambient artificial intelligence for automated multidisciplinary tumor board documentation.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

SpliceImpactR maps alternative RNA processing events driving protein functional diversity.

Nucleic acids research·2026

Large language models in hepatology: A systematic review.

Hepatology forum·2026

Development of adaptive activation functions with curvature and range modulation for abstract image feature learning in complex CNNs for cross-domain applications.

PloS one·2026

OphthoChat: A HIPAA-Compliant, Artificial Intelligence-Driven Natural-Language Chatbot for Ophthalmic Electronic Medical Record Querying and Analysis.

Ophthalmology science·2026

A Locally Executed Agentic Artificial Intelligence Framework for Deduplication, Screening, and Structured Data Extraction in Spine Surgery Systematic Reviews: A PRISMA-Transparent Reporting of Artificial Intelligence in Comprehensive Evidence Synthesis-Compliant Evaluation.

JB & JS open access·2026

Passive non-line-of-sight imaging with diffuse-aware attention-enhanced encoding.

Optics express·2026

Related Experiment Videos

Artificial neural networks: a new model for assessing prognostic factors

Related Concept Videos

Artificial neural networks in urology: Update 2000.

Neural network analysis of the prediction of cancer recurrence following debulking laparotomy and chemotherapy in stages III and IV ovarian cancer.

Impact of different variables on the outcome of patients with clinically confined prostate carcinoma: prediction of pathologic stage and biochemical failure using an artificial neural network.

Evaluation of artificial neural networks for the prediction of pathologic stage in prostate carcinoma.

The problem of cutoff levels in a screened population: appropriateness of informing screenees about their risk of having prostate carcinoma.

Neural network and regression predictions of 5-year survival after colon carcinoma treatment.

Nivolumab plus chemotherapy or ipilimumab versus chemotherapy as first-line treatment for advanced esophageal squamous cell carcinoma: 5-year follow-up results from CheckMate 648.

SKYSCRAPER-03: A Phase III Study of Tiragolumab Plus Atezolizumab Versus Durvalumab in Locally Advanced, Unresectable, Stage III NSCLC After Platinum-Based Concurrent Chemoradiation.

A Multimodal Deep Learning Model for Preoperative Prediction of Postoperative Complications in Gastric Cancer.

SACI-IO HR+: a randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer.

Becotatug vedotin for recurrent/metastatic nasopharyngeal carcinoma (Magic-M001): a multicenter, randomized trial.

Prompt-directed ambient artificial intelligence for automated multidisciplinary tumor board documentation.

SpliceImpactR maps alternative RNA processing events driving protein functional diversity.

Large language models in hepatology: A systematic review.

Development of adaptive activation functions with curvature and range modulation for abstract image feature learning in complex CNNs for cross-domain applications.

OphthoChat: A HIPAA-Compliant, Artificial Intelligence-Driven Natural-Language Chatbot for Ophthalmic Electronic Medical Record Querying and Analysis.

A Locally Executed Agentic Artificial Intelligence Framework for Deduplication, Screening, and Structured Data Extraction in Spine Surgery Systematic Reviews: A PRISMA-Transparent Reporting of Artificial Intelligence in Comprehensive Evidence Synthesis-Compliant Evaluation.

Passive non-line-of-sight imaging with diffuse-aware attention-enhanced encoding.

Related Experiment Videos

Artificial neural networks: a new model for assessing prognostic factors

Related Concept Videos

Related Articles